Health care resources utilisation and costs in patients with non-IPF progressive fibrosing interstitial lung disease

A. Olson (Denver, United States of America), T. Maher (London, United Kingdom), M. Salisbury (Ann Arbor, United States of America), V. Acciai (Ingelheim am Rhein, Germany), B. Mounir (Ingelheim am Rhein, Germany), M. Quaresma (Ingelheim am Rhein, Germany), L. Zouad-Lejour (Ingelheim am Rhein, Germany), C. Wells (Burlington, United States of America), A. Fischer (Denver, United States of America)

Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session: CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Session type: Poster Discussion
Number: 3658
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Olson (Denver, United States of America), T. Maher (London, United Kingdom), M. Salisbury (Ann Arbor, United States of America), V. Acciai (Ingelheim am Rhein, Germany), B. Mounir (Ingelheim am Rhein, Germany), M. Quaresma (Ingelheim am Rhein, Germany), L. Zouad-Lejour (Ingelheim am Rhein, Germany), C. Wells (Burlington, United States of America), A. Fischer (Denver, United States of America). Health care resources utilisation and costs in patients with non-IPF progressive fibrosing interstitial lung disease. 3658

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Health care system resource utilisation in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Palliative and symptomatic care of patients with fibrotic interstitial lung disease
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018

Intensive care outcomes in patients with diffuse fibrotic parenchymal lung diseases
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011

Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need
Source: Breathe, 16 (3) 200066; 10.1183/20734735.0066-2020
Year: 2020



Review of care in patients dying of pulmonary fibrosis in a district general hospital
Source: International Congress 2016 – Orphan diseases I
Year: 2016


The physical and psychological needs of patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016


End-of-life care in in-patients dying from pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016


Diagnostic delay and misdiagnosis in interstitial lung disease(ILD) at primary health care level
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


Palliative and end-of-life care for patients with respiratory disease
Source: Eur Respir Mon; 2009: 43:327–353
Year: 2009

Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180078; 10.1183/16000617.0078-2018
Year: 2018



Impact of early referral to palliative care in patients with interstitial lung disease
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Predictors of high utilization of health care services in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001

EPIDIA: an App to to assist physicians in the care of patients with interstitial lung diseases
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021


Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010

Health care utilization of chronic obstructive pulmonary disease in Korea
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007


Integrated care prevents hospitalisations for exacerbations in COPD patients
Source: Eur Respir J 2006; 28: 123-130
Year: 2006



Benefits from a program for “early interstitial lung diseases” in primary care centers
Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Year: 2017




Clinical impact of an interstitial lung disease Nurse on patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018



Do physicians in primary health care recognize pulmonary fibrosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015